{
    "clinical_study": {
        "@rank": "93892", 
        "acronym": "MAESTRALE", 
        "arm_group": [
            {
                "arm_group_label": "Cohort first decade", 
                "description": "Patients born between 01/01/1979 and 12/31/1984"
            }, 
            {
                "arm_group_label": "Cohort second decade", 
                "description": "Patients born between 01/01/1991 and 12/31/1996"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to describe two cohorts of cystic fibrosis patients treated in\n      2 different decades in terms of FEV1 (Forced Expiratory Volume in one second) maintenance."
        }, 
        "brief_title": "Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to describe two cohorts of cystic fibrosis patients treated in\n      terms of FEV1 maintenance from the age of 10 to 15 before and after 2000."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with Cystic Fibrosis diagnosed with neo-natal screening\n\n          -  Patients born between 01/01/1979 and 12/31/1984 (Cohort 1)and patients born between\n             01/01/1991 and 12/31/1996 (Cohort 2)\n\n          -  Patients with at least 2 FEV1 yearly measurements from the age of 10 to 15\n\n        Exclusion Criteria:\n\n          -  Patients with malignant tumor\n\n          -  Patients with meconium ileus\n\n          -  Patients with transplantation (pneumectomy or lobectomy)\n\n          -  Patients involved in any other clinical trial\n\n          -  Patients moved to another Clinical Center"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "10 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients affected with Pseudomonas A. living in the N-E area of Italy."
            }
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651455", 
            "org_study_id": "MAESTRALE"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cystic Fibrosis", 
            "Pseudomonas Aeruginosa"
        ], 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Verona", 
                    "country": "Italy", 
                    "state": "Veneto", 
                    "zip": "37126"
                }, 
                "name": "U.O. Azienda Ospedaliera"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "2", 
        "official_title": "Maintaining Lung Function in Cystic Fibrosis Patients: Evaluation and Comparison Between Two Decades in a Retrospective Monocentric Observational Study", 
        "overall_official": {
            "affiliation": "U.O. Fibrosi Cistica Azienda Ospedaliera Verona", 
            "last_name": "Baroukh Maurice Assael, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "To describe the difference in terms of FEV1 decline between two cohorts of cystic fibrosis patients", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651455"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To identify clinical parameters or treatments correlated to FEV1 maintenance in two cohorts of cystic fibrosis patients", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "To evaluate the number of patients with Pseudomonas Aeruginosa infection during observational period", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "To describe length of time without Pseudomonas A. infection in non-colonized patients during observational period.", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Chiesi Farmaceutici S.p.A.", 
        "sponsors": {
            "collaborator": {
                "agency": "Medidata Solutions", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Chiesi Farmaceutici S.p.A.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}